Corticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab

Mod Rheumatol. 2015 Sep;25(5):810-1. doi: 10.3109/14397595.2015.1021138. Epub 2015 Jun 12.

Authors

Ryota Sakai¹, Akiko Shibata, Kentaro Chino, Tsuneo Kondo, Ayumi Okuyama, Hirofumi Takei, Koichi Amano

Affiliation

¹ a Department of Rheumatology and Clinical Immunology , Saitama Medical Center, Saitama Medical University , 1981 Kamoda, Kawagoe , Japan.

PMID: 25736354
DOI: 10.3109/14397595.2015.1021138

No abstract available

Keywords: Anti-neutrophil cytoplasmic antibody-associated vasculitis; Corticosteroids; Cyclophosphamide; Interleukin-6; Tocilizumab.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
Antibodies, Monoclonal, Humanized / therapeutic use*
Biopsy
Contraindications
Cyclophosphamide*
Glucocorticoids*
Humans
Male
Tomography, X-Ray Computed

Substances

Antibodies, Monoclonal, Humanized
Glucocorticoids
Cyclophosphamide
tocilizumab